Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility

Obesity increases the risk of anovulation, insulin resistance, hyperandrogenism, and endometrial dysfunction, resulting in women with infertility and increasing preconceptional and pregnancy complications. Bariatric surgery has been described as the most effective intervention for obesity, with impr...

Full description

Saved in:
Bibliographic Details
Main Authors: Paulo César Gete Palacios, Alberto Moscona-Nissan, Renata Saucedo, Aldo Ferreira-Hermosillo
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/15/4/260
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850144310353199104
author Paulo César Gete Palacios
Alberto Moscona-Nissan
Renata Saucedo
Aldo Ferreira-Hermosillo
author_facet Paulo César Gete Palacios
Alberto Moscona-Nissan
Renata Saucedo
Aldo Ferreira-Hermosillo
author_sort Paulo César Gete Palacios
collection DOAJ
description Obesity increases the risk of anovulation, insulin resistance, hyperandrogenism, and endometrial dysfunction, resulting in women with infertility and increasing preconceptional and pregnancy complications. Bariatric surgery has been described as the most effective intervention for obesity, with improved fertility outcomes. However, its invasive nature increases the potential of nutritional deficiencies and the need for a delayed conception post-surgery. On the other hand, pharmacological treatments such as glucagon-like-peptide 1 receptor agonists offer non-invasive alternatives with promising results in body weight, improving insulin sensitivity and restoring ovarian function. However, their use must be discontinued before conception due to potential fetal risks. Other available pharmacological treatment options encompass topiramate, phentermine, and Orlistat. The choice of treatment must be individualized considering cost-effectiveness, accessibility, obesity severity, reproductive goals, and associated risks within each patient. A multidisciplinary approach is essential to optimize metabolic and reproductive health in obesity and infertility. This review will examine the impact on metabolism when comparing surgical and pharmacological interventions for weight loss in women with infertility.
format Article
id doaj-art-a1751694ca3a4dee89fbba5cc1a84cea
institution OA Journals
issn 2218-1989
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj-art-a1751694ca3a4dee89fbba5cc1a84cea2025-08-20T02:28:24ZengMDPI AGMetabolites2218-19892025-04-0115426010.3390/metabo15040260Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with InfertilityPaulo César Gete Palacios0Alberto Moscona-Nissan1Renata Saucedo2Aldo Ferreira-Hermosillo3 Unidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, México City 06720, Mexico Unidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, México City 06720, Mexico Unidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, México City 06720, Mexico Unidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, México City 06720, MexicoObesity increases the risk of anovulation, insulin resistance, hyperandrogenism, and endometrial dysfunction, resulting in women with infertility and increasing preconceptional and pregnancy complications. Bariatric surgery has been described as the most effective intervention for obesity, with improved fertility outcomes. However, its invasive nature increases the potential of nutritional deficiencies and the need for a delayed conception post-surgery. On the other hand, pharmacological treatments such as glucagon-like-peptide 1 receptor agonists offer non-invasive alternatives with promising results in body weight, improving insulin sensitivity and restoring ovarian function. However, their use must be discontinued before conception due to potential fetal risks. Other available pharmacological treatment options encompass topiramate, phentermine, and Orlistat. The choice of treatment must be individualized considering cost-effectiveness, accessibility, obesity severity, reproductive goals, and associated risks within each patient. A multidisciplinary approach is essential to optimize metabolic and reproductive health in obesity and infertility. This review will examine the impact on metabolism when comparing surgical and pharmacological interventions for weight loss in women with infertility.https://www.mdpi.com/2218-1989/15/4/260obesityfemale fertilitypregnancyfemale sexual function
spellingShingle Paulo César Gete Palacios
Alberto Moscona-Nissan
Renata Saucedo
Aldo Ferreira-Hermosillo
Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
Metabolites
obesity
female fertility
pregnancy
female sexual function
title Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
title_full Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
title_fullStr Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
title_full_unstemmed Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
title_short Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
title_sort impact on metabolism generated by surgical and pharmacological interventions for weight loss in women with infertility
topic obesity
female fertility
pregnancy
female sexual function
url https://www.mdpi.com/2218-1989/15/4/260
work_keys_str_mv AT paulocesargetepalacios impactonmetabolismgeneratedbysurgicalandpharmacologicalinterventionsforweightlossinwomenwithinfertility
AT albertomosconanissan impactonmetabolismgeneratedbysurgicalandpharmacologicalinterventionsforweightlossinwomenwithinfertility
AT renatasaucedo impactonmetabolismgeneratedbysurgicalandpharmacologicalinterventionsforweightlossinwomenwithinfertility
AT aldoferreirahermosillo impactonmetabolismgeneratedbysurgicalandpharmacologicalinterventionsforweightlossinwomenwithinfertility